Steroid bill gains strength
This article was originally published in The Tan Sheet
Executive Summary
Senate passes Anabolic Steroid Control Act of 2004 (S 2195) by unanimous consent Oct. 6. The bill, which makes a number of steroid precursors controlled substances, will now head to conference; the House passed a similar measure in June (1"The Tan Sheet" June 7, 2004, p. 13). The bill was stripped of a provision sought by Sen. Richard Durbin (D-Ill.) in September that would have required mandatory adverse event reporting in the Senate judiciary committee (2"The Tan Sheet" Oct. 4, 2004, In Brief)...
You may also be interested in...
Anabolic Steroid Act Heads To Senate After Clearing House 408-3
The Anabolic Steroid Control Act was sent to the Senate June 3 after passing the House with its exemption for dehydroepiandrosterone intact
Investors Go Berserk For Viking, Putting It Top Of Q1 Winners
The top 10 biggest share price winners and losers in Q1 from Evaluate show the investor frenzy for obesity drugs continues, while companies with governance doubts see shareholders retreat.
EU Consults On What Constitutes Personal & Commercially Confidential Data In Marketing Applications
Based on their experience with dealing with requests for access to documents over the past 12 years, EU regulators have proposed updating their guideline that provides for a harmonized approach to protecting personal data and business secrets in marketing authorization applications.